Product Code: ETC11423182 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Advanced Therapy Medicinal Products CDMO Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Advanced Therapy Medicinal Products CDMO Market - Industry Life Cycle |
3.4 Canada Advanced Therapy Medicinal Products CDMO Market - Porter's Five Forces |
3.5 Canada Advanced Therapy Medicinal Products CDMO Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Canada Advanced Therapy Medicinal Products CDMO Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.7 Canada Advanced Therapy Medicinal Products CDMO Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Canada Advanced Therapy Medicinal Products CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing demand for advanced therapy medicinal products (ATMPs) in Canada due to increasing prevalence of chronic diseases. |
4.2.2 Government initiatives and funding to support research and development in the ATMP sector. |
4.2.3 Technological advancements in manufacturing processes leading to improved efficiency and quality of ATMPs. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and approval processes for ATMPs in Canada. |
4.3.2 Limited availability of skilled workforce with expertise in ATMP manufacturing. |
4.3.3 High costs associated with setting up and operating ATMP manufacturing facilities. |
5 Canada Advanced Therapy Medicinal Products CDMO Market Trends |
6 Canada Advanced Therapy Medicinal Products CDMO Market, By Types |
6.1 Canada Advanced Therapy Medicinal Products CDMO Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Canada Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 Canada Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Gene Therapy, 2021 - 2031F |
6.1.4 Canada Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Cell Therapy, 2021 - 2031F |
6.1.5 Canada Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Tissue-Engineered Products, 2021 - 2031F |
6.2 Canada Advanced Therapy Medicinal Products CDMO Market, By Service |
6.2.1 Overview and Analysis |
6.2.2 Canada Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Manufacturing, 2021 - 2031F |
6.2.3 Canada Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Research & Development, 2021 - 2031F |
6.2.4 Canada Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 Canada Advanced Therapy Medicinal Products CDMO Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Canada Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.3 Canada Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Biotechnology Companies, 2021 - 2031F |
6.3.4 Canada Advanced Therapy Medicinal Products CDMO Market Revenues & Volume, By Hospitals & Clinics, 2021 - 2031F |
7 Canada Advanced Therapy Medicinal Products CDMO Market Import-Export Trade Statistics |
7.1 Canada Advanced Therapy Medicinal Products CDMO Market Export to Major Countries |
7.2 Canada Advanced Therapy Medicinal Products CDMO Market Imports from Major Countries |
8 Canada Advanced Therapy Medicinal Products CDMO Market Key Performance Indicators |
8.1 Average manufacturing cycle time for ATMPs. |
8.2 Number of ATMP clinical trials conducted in Canada. |
8.3 Percentage of ATMP manufacturing facilities meeting regulatory compliance standards. |
8.4 Rate of adoption of automation and digital technologies in ATMP manufacturing processes. |
8.5 Investment in research and development for ATMP innovation. |
9 Canada Advanced Therapy Medicinal Products CDMO Market - Opportunity Assessment |
9.1 Canada Advanced Therapy Medicinal Products CDMO Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Canada Advanced Therapy Medicinal Products CDMO Market Opportunity Assessment, By Service, 2021 & 2031F |
9.3 Canada Advanced Therapy Medicinal Products CDMO Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Canada Advanced Therapy Medicinal Products CDMO Market - Competitive Landscape |
10.1 Canada Advanced Therapy Medicinal Products CDMO Market Revenue Share, By Companies, 2024 |
10.2 Canada Advanced Therapy Medicinal Products CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |